GeneMatrix Inc (109820) — Cash Flow Reinvestment Rate
GeneMatrix Inc (109820) has a Cash Flow Reinvestment Rate of 0.13x as of September 2025, reinvesting ₩63.17 Million (capex ₩23.65 Million plus investments ₩-39.52 Million) from operating cash flow of ₩500.19 Million. Explore 109820 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GeneMatrix Inc Cash Flow Reinvestment Rate (2020–2021)
Historical reinvestment intensity for GeneMatrix Inc across 2 annual periods. Also explore total assets of GeneMatrix Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for GeneMatrix Inc (2020–2021)
Year-by-year capital reinvestment analysis for GeneMatrix Inc. For live market cap and broader valuation context, see GeneMatrix Inc (109820) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.31x | ₩1.04 Billion | ₩3.37 Billion | ₩258.22 Million | ▼ -15.2% |
| 2020 | 0.36x | ₩1.64 Billion | ₩4.51 Billion | ₩366.56 Million | — |